Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | PMC:PMC10752363 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
Effects of Extended-Release Buprenorphine on Mouse Models of Influenza
In this study, BALB/c and DBA/2 mice were inoculated with influenza virus, and treatment groups received either no analgesics or 2 doses of extended-release buprenorphine 72 h apart. Clinical signs, mortality, and influenza-specific antibody responses were comparable in mice that did or did not receive buprenorphine. We therefore conclude that extended-release buprenorphine can be used to alleviate incidental pain during studies of influenza infection without altering the course of infection or the immune response.PMID:38110195 | DOI:10.30802/AALAS-CM-23-000049 (Source: Comparative Medicine)
Source: Comparative Medicine - December 18, 2023 Category: Zoology Authors: Marie E Brake Brynnan P Russ Shane Gansebom Sarah C Genzer Cassandra Tansey Ian A York Source Type: research
